Previous 10 | Next 10 |
510(k) clearance will allow 23andMe to report an additional 41 genetic variants in the BRCA1 and BRCA2 genes that increase risk for breast, ovarian, prostate and pancreatic cancer Many of these additional variants occur more often in people of African American and Hispanic/Latino de...
2023-08-25 05:10:00 ET Recursion Pharmaceuticals (NASDAQ: RXRX) and 23andMe (NASDAQ: ME) are both popular biotech stocks that are wooing investors with their claims about using artificial intelligence (AI) to supercharge the drug development process. But over the last three ...
2023-08-23 15:31:11 ET More on Thorne HealthTech Thorne HealthTech, Inc ( THRN ) Q2 2023 Earnings Call Transcript Thorne HealthTech, Inc. 2023 Q2 - Results - Earnings Call Presentation Thorne HealthTech: Solid 2023 Outlook With A Short-Term Pullback Risk ...
Toronto, Ontario--(Newsfile Corp. - August 23, 2023) - Moneta Gold Inc. (TSX: ME) (OTCQX: MEAUF) (FSE: MOPA) ("Moneta" or the "Company") is pleased to announce that the Company has completed 2 separate transactions and acquired 2 land packages adjacent to its wholly owned Loveland Nickel prop...
2023-08-09 17:24:00 ET Genetic-testing company and researcher 23andMe Holding (NASDAQ: ME) wasn't testing very well with investors on Wednesday. They assertively sold out of the company's shares, to the point where the shares ended the day down by nearly 13%. That was a far stee...
2023-08-08 19:52:10 ET 23andMe Holding Co. (ME) Q1 2024 Results Conference Call August 08, 2023 04:30 PM ET Company Participants Katie Watson - Vice President of Communications Anne Wojcicki - Chief Executive Officer and Co-Founder Joe Selsavage - Interim Chief F...
2023-08-08 16:18:13 ET 23andMe press release ( NASDAQ: ME ): Q1 GAAP EPS of -$0.23 misses by $0.04 . Revenue of $60.86M (-5.6% Y/Y) beats by $3.96M . Revenue guidance for FY2024, which will end on March 31, 2024, is reaffirmed to be in the range of $255 million...
Reaffirmed Full Year Revenue Guidance and Raised Full Year Guidance for Net Loss and Adjusted EBITDA Deficit Webcast at 4:30 pm ET, August 8, 2023 SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics an...
2023-08-07 08:34:22 ET Missfresh ( MF ) +51% a nnounces Entry into Share Transfer Agreement. Sequans Communications ( SQNS ) +31% Q2 earnings call release Tabula Rasa HealthCare ( TRHC ) +30% Reports Second Quarter 2023 Financial Results. ...
2023-08-06 08:01:00 ET The second week of August promises to be an eventful one for investors as a slew of major companies is set to report quarterly results. Among the headliners, Disney ( NYSE: DIS ) is prehaps the most well-known company due to report. The schedule also incl...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial resu...
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading genetic health and biopharmaceutical company, in collaboration with 20 lung cancer advocacy organizations, today announced a new study to help advance research in lung cancer. The focus of the Lun...